| ［1］ |
中华医学会皮肤性病学分会免疫学组. 中国荨麻疹诊疗指南（2014版）［J］. 中华皮肤科杂志, 2014, 47（7）: 514⁃516. DOI: 10.3760/cma.j.issn.0412⁃4030.2014.07.019.
|
| ［2］ |
Finlay AY, Khan GK. Dermatology life quality index （DLQI）--a simple practical measure for routine clinical use［J］. Clin Exp Dermatol, 1994, 19（3）: 210⁃216. DOI: 10.1111/j.1365⁃2230. 1994.tb01167.x.
|
| ［3］ |
邓英键, 张晓玲, 杨如学, 等. 咪唑斯汀治疗慢性荨麻疹的临床疗效观察［J］. 临床皮肤科杂志, 2013, 42（1）: 49⁃50. DOI:10.3969/j.issn.1000⁃4963.2013.01.026.
|
| ［4］ |
Molyva D, Kalokasidis K, Poulios C, et al. Rupatadine effectively prevents the histamine⁃induced up regulation of histamine H1R and bradykinin B2R receptor gene in the rat paw［J］. Pharmacol Rep, 2014, 66（6）: 952⁃955. DOI: 10.1016/j.pharep. 2014.06.008.
|
| ［5］ |
卜今, 陈志强. 卢帕他定——新型的组胺H1受体和血小板活化因子受体双重拮抗剂［J］. 中国中西医结合皮肤性病学杂志, 2006, 5（3）: 182⁃184. DOI: 10.3969/j.issn.1672⁃0709.2006. 03.030.
|
| ［6］ |
Mullol J, Bousquet J, Bachert C, et al. Update on rupatadine in the management of allergic disorders［J］. Allergy, 2015, 70 Suppl 100: 1⁃24. DOI: 10.1111/all.12531.
|
| ［7］ |
Siebenhaar F, Förtsch A, Krause K, et al. Rupatadine improves quality of life in mastocytosis: a randomized, double⁃blind, placebo⁃controlled trial［J］. Allergy, 2013, 68（7）: 949⁃952. DOI: 10.1111/all.12159.
|
| ［8］ |
杨婧芝, 熊玉卿. 抗变态反应药物富马酸卢帕他定的药理及临床评价［J］. 中国新药杂志, 2011, 20（20）: 1937⁃1940.
|
| ［9］ |
Abajian M, Curto⁃Barredo L, Krause K, et al. Rupatadine 20 mg and 40 mg are effective in reducing the symptoms of chronic cold urticaria［J］. Acta Derm Venereol, 2016, 96（1）: 56⁃59. DOI: 10.2340/00015555⁃2150.
|
| ［10］ |
Nettis E, Delle DP, Di LE, et al. Rupatadine for the treatment of urticaria［J］. Expert Opin Pharmacother, 2013, 14（13）: 1807⁃1813. DOI: 10.1517/14656566.2013.813481.
|
